Healthcare IT News February 15, 2021
Kat Jercich

The research team noted that lung tissue gets stiffer as a person gets older, showing different patterns of gene expression than in younger people.

The Massachusetts Institute of Technology announced this week that researchers had used machine learning to identify medications that may be repurposed to fight COVID-19.

“Making new drugs takes forever,” Caroline Uhler, a computational biologist in MIT’s Department of Electrical Engineering and Computer Science and the Institute for Data, Systems and Society, said in a press statement. “Really, the only expedient option is to repurpose existing drugs.”

The research from Uhler’s team, which appears in the journal Nature Communications, notes that the novel coronavirus tends to have much more severe effects in older patients.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID, Technology
How healthcare's view of AI has shifted
The Power of Drug Discovery with Philip Tagari
Bite-Sized AI: Why Smaller Models Like Microsoft’s Phi-3 Are Big for Business
Coventry Uni uses AI-generated avatars to train medical students
Lessons on generative AI in medicine from Stanford University

Share This Article